Drugs & Treatments

/Drugs & Treatments

prostate cancer drugs and treatments that are available

One Man’s Shares His Personal Tips About Having Provenge To Treat His Advanced Prostate Cancer

The following was posted on the Malecare Advanced Prostate Cancer Health Unlocked online support group.  I have received permission to reprint it here because it might be helpful to some of you. FYI-    Provenge is a cancer vaccine that helps to mobilize your own immune system to your prostate cancer.  It is currently only approved in the United States for men who castrate resistant. It is administered by first removing a bag of your white blood cells, sending them off to a factory in Seale Beacj Calif. where the white cells (T cells) are altered by having a protein [...]

By | December 9th, 2016|Drugs & Treatments, General Information, immunotherapy, Provenge|0 Comments

Cognition and Hormone Therapy (ADT)

There have been numerous studies examining the how hormone deprivation (ADT), in the treatment of prostate cancer, has on a man’s cognition. There have been contradictor studies about this issue, however having had the experience and the honor of dealing with so many men with prostate cancer treated with androgen deprivation therapy (ADT), as well as my own personal experience, I must fall in line and agree with an online published study that shows that men on ADT are likely to experience cognitive impairment of some type. The study was small, as all of the other studies have been, followed [...]

Vitamin D3 Potentiates Metformin in DU145 Human Prostate Cancer Cells

It is well established that common drugs like Metformin and vitamin D? exhibit a strong anti-proliferative action in many cancer cell lines. Recent research confirms that this is also true in human prostate cancer cells. In a recent study it was demonstrated that the combination of the two drugs, metformin and vitamin D3, had a much stronger positive effect on DU145 human prostate cancer cell growth than either drug alone. These two drugs showed a synergistic effect on cell proliferation and apoptosis. Most of us do not know the genetic structure of our cancer tumor, so we do not know [...]

By | November 17th, 2016|Metformin, Research, Vitamine D3|0 Comments

Enzalutamide Prescribing Info Includes New Information

Enzalutamide (Xtandi) has a new, expanded FDA label. The new label conforms with the clinical trial (TERRAIN) results that Xtandi is a superior drug to Casodex (bicalutamide) for men with metastatic castration-resistant prostate cancer (CRPC). The updated product label shows enzalutamide reduces the risk of radiographic progression or death by 40% vs. bicalutamide. Median radiographic progression-free survival was 19.5 months with enzalutamide compared with 13.4 months with bicalutamide. Steven Benner, MD, senior vice president, therapeutic area head for oncology development, Astellas, said in a statement, "The addition of data from the TERRAIN trial continues to build the body of evidence [...]

By | October 26th, 2016|Casodex, enzalutamide, Uncategorized, Xtandi|0 Comments
スーパーコピーブランド ロレックススーパーコピー オメガスーパーコピー ブルガリスーパーコピー ブライトリングスーパーコピー カルティエスーパーコピー シャネル時計コピー IWCスーパーコピー フランクミュラースーパーコピー パネライスーパーコピー タグホイヤースーパーコピー ウブロスーパーコピー ガガミラノスーパーコピー ルイヴィトンスーパーコピー シャネルスーパーコピー エルメススーパーコピー グッチスーパーコピー ボッテガヴェネタスーパーコピー プラダスーパーコピー セリーヌスーパーコピー ロレックススーパーコピー ウブロスーパーコピー